Skip to main content

Table 2 Median and mean patient, diagnostic, referral and treatment time intervals

From: The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting

  Patient interval (wks) Healthcare practitioner interval (wks) Referral interval (wks) Treatment interval (wks)
n Median p n Median p n Median p n Median p
Sex
 Female 57 2 0.14 60 8 0.85 65 2 0.56 65 2 0.97
 Male 71 4   73 7   87 2   91 1  
Age
  < 50 yr 75 4 0.59 79 6 0.26 88 2 0.54 88 2 0.27
50 53 3   54 7   64 2   68 1  
HIV
 Negative 91 4 0.41 93 7 0.58 105 2 0.20 112 1 0.29
 Positive 37 2   40 8   47 2   44 2  
Lymphoma type
 NHL 96 3 0.15 99 6 0.01 112 2 0.64 117 1 < 0.01
 HL 32 4   34 12   40 2   39 3  
Performance score
 ECOG 0 17 4 0.43 17 6 0.43 18 3 0.52 18 2 0.01
 ECOG 1 57 4   59 8   71 2   73 2  
 ECOG 2 19 2   21 9   23 2   27 1  
 ECOG 3 25 2   25 7   29 2   28 1  
 ECOG 4 10 2   11 5   11 2   10 2  
FNAC
 Not performed 76 3 0.38 78 5 0.04 91 2 0.86 94 1 0.08
 Performed 52 4   55 9   61 2   62 2  
Stage
 Early-stage 45 3 0.66 47 4 0.02 56 2 0.12 58 2 0.16
 Late-stage 83 4   86 9   96 2   98 1  
Clinical characteristics
 No peripheral lymph nodes 42 2 0.03 43 6 0.24 52 2 0.13 57 1 0.02
 Peripheral lymph nodes 86 4   90 7   100 2   99 2  
 No B symptoms 57 3 0.17 58 4 0.08 64 2 0.22 66 2 0.46
 B Symptoms present 71 4   75 9   88 2   90 2  
 Not on TB therapy 115 4 0.82 118 6 0.28 136 2 0.72 141 2 0.45
 On TB therapy at diagnosis 13 3   15 10   16 2   15 2  
 iagnosis made on lymph node 120 4 0.02 125 7 0.75 144 2 0.10 147 1 0.44
 Diagnosis made on bone marrow 8 1   8 9   8 1   9 2